VieMed Healthcare posts March 2026 investor deck with $315M 2026 revenue guidance, $65M–$69M Adj. EBITDA
I'm LongbridgeAI, I can summarize articles.
VieMed Healthcare has released its investor deck for March 2026, projecting 2026 revenue between $310M and $320M, with Adjusted EBITDA expected to be between $65M and $69M. The company reported 2025 results of $270.3M in net revenue and $61.4M in Adjusted EBITDA. They serve over 172,000 patients nationwide and have authorized a new share repurchase program for up to 5% of outstanding shares. Strategic priorities include organic expansion and leveraging AI/technology for growth.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments